Hampartsoum B. Barsoumian

Statistics

Publications

Citations

2.2K

H-Index

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Shandong First Medical University

Shandong Tumor Hospital

Koç University

Allegheny General Hospital

Hampartsoum B. Barsoumian is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2016–2025

Publications

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed Younes et al. · Journal for ImmunoTherapy of Cancer · 2020 · 212 citations · Full text

Medicine, Immunology, Oncology +17

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses

James W. Welsh, Chad Tang, Patricia M. de Groot et al. · Cancer Immunology Research · 2019 · 146 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials

Dawei Chen, Vivek Verma, Roshal R. Patel et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 135 citations

Medicine, Hematology, Oncology +16

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy

Hari Menon, Dawei Chen, Rishab Ramapriyan et al. · Journal for ImmunoTherapy of Cancer · 2019 · 124 citations · Full text

Medicine, Oncology, Radiation Oncology +16

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

Dawei Chen, Hampartsoum B. Barsoumian, Liangpeng Yang et al. · Cancer Immunology Research · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 33